XBIOTECH INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
XBIOTECH INC. (XBIT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 11.80 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-13
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 3.00K shares.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 8.80K shares, a 99.17% decline year-over-year.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 278.22K shares, a 415.22% increase year-over-year.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 29.43K shares, a 881.07% increase year-over-year.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.37M shares, a 424.33% increase from fiscal 2024.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 262.00K shares, a 67.64% decline from fiscal 2023.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 809.60K shares, a 430.54% increase from fiscal 2022.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 152.60K shares, a 81.15% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 3.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 11.80K shares 10-Q · filed 2026-08-13 | 290.02K shares derived: sum of 3 quarters · filed 2026-08-13 | 319.45K shares derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | 8.80K shares 10-Q · filed 2026-05-14 | 287.02K shares derived: sum of 2 quarters · filed 2026-05-14 | 316.45K shares derived: sum of 3 quarters · filed 2026-05-14 | 316.45K shares derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | 278.22K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 307.65K shares derived: sum of 2 quarters · filed 2026-03-13 | 307.65K shares derived: sum of 3 quarters · filed 2026-08-13 | 1.37M shares 10-K · filed 2026-03-13 | |
| 2025-09-30 | 29.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 29.43K shares derived: sum of 2 quarters · filed 2026-08-13 | 1.10M shares 10-Q · filed 2025-11-12 | 1.15M shares derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 1.07M shares 10-Q · filed 2026-08-13 | 1.12M shares derived: sum of 3 quarters · filed 2026-08-13 | 1.12M shares derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | 1.07M shares 10-Q · filed 2026-05-14 | 1.12M shares derived: sum of 2 quarters · filed 2026-05-14 | 1.12M shares derived: sum of 3 quarters · filed 2026-05-14 | 1.31M shares derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | 54.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 57.00K shares derived: sum of 2 quarters · filed 2026-03-13 | 239.00K shares derived: sum of 3 quarters · filed 2026-03-13 | 262.00K shares 10-K · filed 2026-03-13 | |
| 2024-09-30 | 3.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 185.00K shares derived: sum of 2 quarters · filed 2025-11-12 | 208.00K shares 10-Q · filed 2025-11-12 | 208.00K shares derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | 182.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 205.00K shares 10-Q · filed 2025-08-13 | 205.00K shares derived: sum of 3 quarters · filed 2025-08-13 | 214.00K shares derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | 23.00K shares 10-Q · filed 2025-05-14 | 23.00K shares derived: sum of 2 quarters · filed 2025-05-14 | 32.00K shares derived: sum of 3 quarters · filed 2025-05-14 | 133.80K shares derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | 9.00K shares derived: sum of 2 quarters · filed 2025-03-18 | 110.80K shares derived: sum of 3 quarters · filed 2025-03-18 | 809.60K shares 10-K · filed 2025-03-18 | |
| 2023-09-30 | 9.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 110.80K shares derived: sum of 2 quarters · filed 2024-11-13 | 809.60K shares 10-Q · filed 2024-11-13 | 810.60K shares derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | 101.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 800.60K shares 10-Q · filed 2024-08-12 | 801.60K shares derived: sum of 3 quarters · filed 2024-08-12 | 806.60K shares derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | 698.80K shares 10-Q · filed 2023-05-10 | 699.80K shares derived: sum of 2 quarters · filed 2024-03-15 | 704.80K shares derived: sum of 3 quarters · filed 2024-03-15 | 837.40K shares derived: sum of 4 quarters · filed 2024-03-15 | |
| 2022-12-31 | 1.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 6.00K shares derived: sum of 2 quarters · filed 2024-03-15 | 138.60K shares derived: sum of 3 quarters · filed 2024-03-15 | 152.60K shares 10-K · filed 2024-03-15 | |
| 2022-09-30 | 5.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 137.60K shares derived: sum of 2 quarters · filed 2023-11-09 | 151.60K shares 10-Q · filed 2023-11-09 | 162.00K shares 10-Q · filed 2022-11-09 | 809.50K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 132.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | 146.60K shares 10-Q · filed 2023-08-11 | 804.50K shares derived: sum of 3 quarters · filed 2023-08-11 | 826.10K shares derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | 14.00K shares 10-Q · filed 2022-05-10 | 671.90K shares derived: sum of 2 quarters · filed 2023-03-15 | 693.50K shares derived: sum of 3 quarters · filed 2023-03-15 | 805.50K shares derived: sum of 4 quarters · filed 2023-03-15 | |
| 2021-12-31 | 657.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | 679.50K shares derived: sum of 2 quarters · filed 2023-03-15 | 791.50K shares derived: sum of 3 quarters · filed 2023-03-15 | 809.50K shares 10-K · filed 2023-03-15 | |
| 2021-09-30 | 21.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 133.60K shares derived: sum of 2 quarters · filed 2022-11-09 | 151.60K shares 10-Q · filed 2022-11-09 | 162.00K shares 10-Q · filed 2021-11-09 | 167.60K shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | 112.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | 130.00K shares 10-Q · filed 2022-08-10 | 146.00K shares derived: sum of 3 quarters · filed 2022-08-10 | 279.00K shares derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | 18.00K shares 10-Q · filed 2021-05-10 | 34.00K shares derived: sum of 2 quarters · filed 2022-03-15 | 167.00K shares derived: sum of 3 quarters · filed 2022-03-15 | 198.00K shares derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-12-31 | 16.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 149.00K shares derived: sum of 2 quarters · filed 2022-03-15 | 180.00K shares derived: sum of 3 quarters · filed 2022-03-15 | 230.50K shares 10-K · filed 2022-03-15 | |
| 2020-09-30 | 133.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 164.00K shares derived: sum of 2 quarters · filed 2020-11-09 | 214.50K shares 10-Q · filed 2020-11-09 | 1.95M shares derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-06-30 | 31.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 81.50K shares 10-Q · filed 2020-08-10 | 1.81M shares derived: sum of 3 quarters · filed 2022-03-15 | 1.95M shares derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-03-31 | 50.50K shares 10-Q · filed 2020-05-11 | 1.78M shares derived: sum of 2 quarters · filed 2022-03-15 | 1.92M shares derived: sum of 3 quarters · filed 2022-03-15 | 2.40M shares derived: sum of 4 quarters · filed 2022-03-15 | |
| 2019-12-31 | 1.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 1.87M shares derived: sum of 2 quarters · filed 2022-03-15 | 2.35M shares derived: sum of 3 quarters · filed 2022-03-15 | 2.56M shares 10-K · filed 2022-03-15 | |
| 2019-09-30 | 139.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 617.50K shares derived: sum of 2 quarters · filed 2019-11-12 | 832.50K shares 10-Q · filed 2019-11-12 | 1.06M shares derived: sum of 4 quarters · filed 2021-03-16 | |
| 2019-06-30 | 478.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 693.50K shares 10-Q · filed 2019-08-09 | 920.50K shares derived: sum of 3 quarters · filed 2021-03-16 | 1.02M shares derived: sum of 4 quarters · filed 2021-03-16 | |
| 2019-03-31 | 215.00K shares 10-Q · filed 2019-05-09 | 442.00K shares derived: sum of 2 quarters · filed 2021-03-16 | 546.00K shares derived: sum of 3 quarters · filed 2021-03-16 | 1.16M shares derived: sum of 4 quarters · filed 2021-03-16 | |
| 2018-12-31 | 227.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 331.00K shares derived: sum of 2 quarters · filed 2021-03-16 | 945.00K shares derived: sum of 3 quarters · filed 2021-03-16 | 1.15M shares 10-K · filed 2021-03-16 | |
| 2018-09-30 | 104.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | 718.00K shares derived: sum of 2 quarters · filed 2018-10-31 | 926.50K shares 10-Q · filed 2018-10-31 | 935.50K shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-06-30 | 614.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 822.50K shares 10-Q · filed 2018-08-09 | 831.50K shares derived: sum of 3 quarters · filed 2020-03-16 | 1.19M shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-03-31 | 208.50K shares 10-Q · filed 2018-05-08 | 217.50K shares derived: sum of 2 quarters · filed 2020-03-16 | 579.50K shares derived: sum of 3 quarters · filed 2020-03-16 | 1.44M shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2017-12-31 | 9.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 371.00K shares derived: sum of 2 quarters · filed 2020-03-16 | 1.23M shares derived: sum of 3 quarters · filed 2020-03-16 | 1.25M shares 10-K · filed 2020-03-16 | |
| 2017-09-30 | 362.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 1.22M shares derived: sum of 2 quarters · filed 2017-11-09 | 1.24M shares 10-Q · filed 2017-11-09 | ||
| 2017-06-30 | 857.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 880.00K shares 10-Q · filed 2017-08-08 | |||
| 2017-03-31 | 23.00K shares 10-Q · filed 2017-05-10 | ||||
| 2016-12-31 | 1.06M shares 10-K/A · filed 2019-03-15 | ||||
| 2016-09-30 | 242.00K shares 10-Q · filed 2016-11-14 | 640.50K shares derived: sum of 2 quarters · filed 2016-11-14 | 998.33K shares derived: sum of 3 quarters · filed 2016-11-14 | ||
| 2016-06-30 | 398.50K shares 10-Q · filed 2016-11-14 | 756.33K shares derived: sum of 2 quarters · filed 2016-11-14 | |||
| 2016-03-31 | 357.83K shares 10-Q · filed 2016-11-14 | ||||
| 2015-12-31 | 375.93K shares 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | 65.90K shares 10-Q · filed 2015-11-13 | 285.43K shares derived: sum of 2 quarters · filed 2015-11-13 | 350.43K shares derived: sum of 3 quarters · filed 2015-11-13 | ||
| 2015-06-30 | 219.53K shares 10-Q · filed 2015-11-13 | 284.53K shares derived: sum of 2 quarters · filed 2015-11-13 | |||
| 2015-03-31 | 65.00K shares 10-Q · filed 2015-11-13 | ||||
| 2014-12-31 | 1.56M shares 10-K · filed 2017-03-16 | ||||
| 2013-12-31 | 40.00K shares 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |